IP Library Granted Patent US 9,003,676
Granted Patent B2
US 9,003,676 · App. 12/140,519 · Granted Apr 14, 2015

Method for lyophilizing an active agent

Inventors: Cody L. Yarborough (Cleburne, TX); Dominic G. Madril (Vallejo, CA); Rajan Bawa (Ft. Collins, CO)
Assignee: Tolmar Therapeutics, Inc.
F26B5/06A61M5/002A61M5/008A61M5/178A61M5/1782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,003,676
App. No.
12/140,519
Granted
Apr 14, 2015
Kind
B2
Abstract

A process for lyophilizing a solution of an active agent in a container is provided. Solution of active agent is deposited into a container, the container is covered with a covering plate and placed inside a lyophilizing apparatus. Lyophilization can be conducted to dryness by radiation, convection or both. Also provided is a device made by this process, an active agent-plastic administration device (e.g., a syringe), containing an active agent in the form of lyophilized cake, and an array of such administration devices.

Claims (10)

1. A process for producing a first group of containers with lyophilized leuprolide acetate comprising

depositing uniform portions of a solution into the containers of the first and a second groups, each container having an opening, each portion of solution containing the same amount of dissolved leuprolide acetate dissolved in a solvent;

aligning a covering plate with an underside and with protuberances attached to the underside of the cover plate so that the protuberances fit through the openings of, and inside of, each of the containers of the first and second groups, the protuberances being adapted to fit inside without contacting any part of the containers of the first and second groups;

placing the first and second groups with fitted cover plate into a lyophilizing apparatus;

at least partially lyophilizing the solution by cooling the solution to a frozen solid, applying a vacuum to the frozen solid and forming a lyophilizate of leuprolide acetate retained in the containers of the first and second groups;

removing the covering plate from the containers of the first and second groups after lyophilization;

examining the covering plate underside and protuberances for escaped leuprolide acetate lyophilizate and identifying containers corresponding to the undersides and protuberances with escaped leuprolide acetate lyophilizate thereby identifying the second group; and

discarding the second group; maintaining the first group of containers identified by the absence of escaped leuprolide acetate lyophilizate on the corresponding undersides and protuberances associated with the first group of containers.

2. The process according to claim 1 wherein the solution contains about 38 mg/ml of leuprolide acetate.

3. The process according to claim 2 wherein the uniform portion of solution deposited into the containers of the first and second groups is about 0.3 ml of aqueous leuprolide acetate.

Assignments (3)
SECURITY INTEREST Recorded Oct 2, 2017
From: TOLMAR THERAPEUTICS, INC.; TOLMAR, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 043756/0502 →
CHANGE OF NAME Recorded Jan 6, 2015
From: QLT USA, INC.
To: TOLMAR THERAPEUTICS, INC.
Reel/Frame 034727/0599 →
MERGER Recorded Jul 8, 2008
From: ATRIX LABORATORIES, INC.
To: QLT USA, INC.
Reel/Frame 021212/0072 →
Continuity (5)
Continuation 11099919 · Apr 6, 2005
Continuation 10391480 · Mar 17, 2003
Continuation In Part 09909671 · Jul 20, 2001
Division 09190341 · Nov 12, 1998
Related Publication 20080244923A1 · Oct 9, 2008